Tsuyoshi Kaneko
Latest contributions
Indication and device selection for tricuspid interventions
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to sharpen your skills in selecting the right patients and devices for transcatheter tricuspid interventions? Don’t miss this session!
Learn how to assess anatomical suitability for T-TEER and TTVR, identify patients who may benefit from replacement over repair and explore the latest insights on timing and...
Lifetime management with self-expandable valve based on the latest evidence
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest evidence on the Evolut system and its impact on long-term valve durability in TAVR. Gain insights into its use for TAV-in-SAV procedures, the role of valve design in optimizing outcomes, and the importance of first-valve selection, commissure alignment, and coronary access.
Imaging aortic valve
09 Feb 2025 – From PCR Tokyo Valves 2025
Explore cutting-edge imaging techniques to assess and guide the management of aortic valve disease in this comprehensive session. From preprocedural assessment with TEE to advanced CT and MRI strategies, learn how to evaluate and treat patients with low-flow low-gradient aortic stenosis, aortic regurgitation, and post-TAVI complications....
How to optimise the patient outcomes - Key considerations for the small body population
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest strategies for optimizing outcomes in Asian and international patients with small body size. Through case presentations, surgical experiences, and the latest data on device performance, gain valuable insights into treating aortic stenosis more effectively. Discover how these advancements can enhance patient care and...
Lifetime management
08 Feb 2025 – From PCR Tokyo Valves 2025
This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...
Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...
Transcatheter options for degenerated surgical aortic valves - LIVE case
Recommended by PCR
08 Feb 2025 – From PCR Tokyo Valves 2025
A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.
A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...
Nightmare in TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this session replay featuring two challenging cases: valve embolisation with a balloon-expandable valve and coronary obstruction with a self-expandable valve. Learn key lessons from the first case, including the importance of secure pacing, avoiding damage to the descending aorta while retrieving the embolised valve, and...
Mind the gap! - What's missing in the field of transcatheter aortic valve interventions
25 Nov 2024 – From PCR London Valves 2024
This session aims to uncover the hidden gaps in the field of transcatheter aortic valve interventions (TAVI). Explore strategies for optimizing hemodynamics, durability, flow, and frame expansion post-TAVI. Review current knowledge and emerging approaches to improve hemodynamic performance, device durability, and flow dynamics after TAVI. Discuss...
TAVI for pure aortic regurgitation - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on aortic regurgitation:
- An 86-year-old male with a history of stroke and prostate cancer presenting acute heart failure due to severe pure aortic regurgitation and LV dysfunction (EF 39%). A 27 mm JenaValve Trilogy prosthesis was implanted without...
Featured cases - Valve-in-valve TAVI with balloon fracture
24 Nov 2024 – From PCR London Valves 2024
Delve into the world of complex valve-in-valve TAVI procedures in this featured cases session. Explore a diverse range of challenging cases, including valve fracture techniques, managing unexpanded valves, and overcoming the Achilles' heel of valve-in-valve TAVI. Learn from the experiences of expert clinicians as they navigate...
Contemporary techniques for TAV-in-SAV interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...
Nightmares in TAVI: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
CAD and TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...
Tricuspid and other structural interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
In this series of submitted cases, explore challenges and bailouts around tricuspid valve intervention and other forms of structural interventions. Learn about a percutaneous solution to acute traumatic pulmonary regurgitation, a rare complication of inadequate sealing caused by anchor slip through the fabric part in a...
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
My worst nightmare in TAVI
Listen to our experts share their most nightmarish TAVI cases and follow the debate around their treatments. For instance, would you make the same choices when faced with a 76-year-old female patient diagnosed as severe AS, transferred for SAVR/TAVI, who got a new Abif and cardiogenic...
TAVI in patients with heavily calcified aortic root
19 Feb 2023 – From PCR Tokyo Valves 2023
What role does TAVI play in patients' severely calcified roots? Study the use of balloon-expandable devices, assessing the impact of calcification on aortic root rupture, strategies for safe and effective procedures, and when to consider surgical AVR.
TAVI and alternative access
19 Feb 2023 – From PCR Tokyo Valves 2023
Learn more about TAVI in this session by reviewing case submissions on topics such as bailout transseptal approach, primary percutaneous transaxillary TAVI, and transapical TAVI with chimney stenting.
Tricuspid valve interventions - All you need to know
18 Feb 2023 – From PCR Tokyo Valves 2023
Gain comprehensive insights into tricuspid valve interventions in this session. Understand patient selection, transcatheter solutions for tricuspid regurgitation, effective procedural imaging, and explore recorded cases of transcatheter tricuspid valve interventions, including replacement and repair options.
The optimal first valve choice for all patients with aortic stenosis
18 Feb 2023 – From PCR Tokyo Valves 2023
How have advances in TAVI impacted the lifetime journey of patients with aortic stenosis? Join this panel of experts as they discuss the importance of optimizing the first procedure and the key issues regarding treatment options in patients with bioprosthetic valve deterioration of transcatheter heart valve.
Lifetime management of patients with aortic stenosis
02 Dec 2022
Watch the 2nd PCR Tokyo Valves 2022 webinar on aortic stenosis.
Combined valve interventions
28 Nov 2022 – From PCR London Valves 2022
Among the very interesting cases presented in this PCR LV 2022 session, watch the 1st case of TMVR and TTVR in a patient with the use of dedicated investigational devices, simultaneous transcatheter mitral and tricuspid approach in a patient with dextrocardia, or simultaneous mitral valve-in-valve, tricuspid...
Ensuring optimal TAVI outcomes - LIVE case
27 Nov 2022 – From PCR London Valves 2022
A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...
Treatment of aortic stenosis in patients with longer life expectancy: case-based heart team discussion
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with a case-based heart team discussion to learn more about the treatment of aortic stenosis in patients with longer life expectancy: discover what the 2021 guidelines say about patient selection, what should be considered for patients with longer life expectancy, and how to optimise procedural outcome.
Case-based challenging TAVI
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations.
